miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.

Wang R, Ma Q, Ji L, Yao Y, Ma M, Wen Q

DOI: 10.2147/ott.s156810
Published: 2018
Container: OncoTargets and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2147/ott.s156810,
  title = {miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.},
  author = {Wang R and Ma Q and Ji L and Yao Y and Ma M and Wen Q},
  year = {2018},
  journal = {OncoTargets and therapy},
  doi = {10.2147/ott.s156810},
  url = {https://doi.org/10.2147/ott.s156810}
}

RIS

TY  - JOUR
TI  - miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.
AU  - Wang R
AU  - Ma Q
AU  - Ji L
AU  - Yao Y
AU  - Ma M
AU  - Wen Q
PY  - 2018
JO  - OncoTargets and therapy
DO  - 10.2147/ott.s156810
UR  - https://doi.org/10.2147/ott.s156810
ER  -

APA

R, W., Q, M., L, J., Y, Y., M, M., & Q, W. (2018). miR-622 suppresses tumor formation by directly targeting VEGFA in papillary thyroid carcinoma.. OncoTargets and therapy. https://doi.org/10.2147/ott.s156810

Source records

pubmed · retrieved 2026-09-24T19:45:22.429Z